FTC Finds PBM-Owned Pharmacies Marked Up Generic Specialty Drugs by $7.3 Billion

The Federal Trade Commission (FTC) recently issued a second interim report concerning the mark-ups on high-cost generic specialty drugs sold at pharmacies owned by the three largest pharmacy benefit managers (PBMs). This report follows a July 2024 report in which the FTC found that the biggest PBMs paid higher drug prices to their pharmacies than other pharmacies.

The PBMs at issue include Cigna’s Express Scripts unit, the CVS Health Caremark unit, and the UnitedHealth Optum Rx unit. These pharmacies charged private health plans and Medicare prescription drug plans $10 billion for 51 specialty drugs between 2017 and 2021, which they obtained for $2.7 billion.

These pharmacies had a total revenue of $2.6 billion in 2021, which increased from $2.1 billion in 2017. However, the FTC staff report did not address the impact of the COVID-19 pandemic or other cost drivers during this timeframe. The FTC report also did not compare the operating margins of these pharmacies with those of other pharmacies.

The FTC initially balked at releasing the report but did so after receiving a letter from a bipartisan group of House members led by Sen. Elizabeth Warren, D-Mass. According to FTC Chair Lina Khan, the report shows that big PBMs use their pharmacies to increase the costs of lifesaving drugs for consumers and push out independent pharmacies. Therefore, Khan states that the FTC needs to continue its investigation into PBMs and related issues.

The PBMs counter that they have sought to negotiate lower drug prices for health plan sponsors and patients. The companies claim that the FTC has relied on their opponents for information. Express Scripts has even sued the FTC for defamation following its last report, alleging that it spent millions providing data that the FTC largely ignored.

HBL has experience in all areas of benefits and employment law, offering a comprehensive solution for your business benefits and HR/employment needs. We help ensure you are in compliance with the complex requirements of ERISA and the IRS code, as well as those laws that impact you and your employees. Together, we reduce your exposure to potential legal or financial penalties. Learn more by calling 470-571-1007.

The following two tabs change content below.

Hall Benefits Law, LLC

HBL offers employers comprehensive legal guidance on benefits in mergers and acquisitions, Employee Stock Ownership Plans (ESOPs), executive compensation, health and welfare benefits, healthcare reform, and retirement plans. We counsel a wide spectrum of clients including small, mid-sized, and large companies, 401(k) investment advisors, health insurance brokers, accountants, attorneys, and HR consultants, just to name a few. HBL is passionate about advising clients, and we are dedicated to our mission: to provide comprehensive, personalized, and practical ERISA and benefits legal solutions that exceed client expectations.